Lateral Elbow Tendinopathy: Evidence-Based Rehab for Clinicians

Lateral elbow tendinopathy (LET) is one of the most common upper limb presentations in primary care and manual therapy practice — and also one of the most undertreated. Not undertreated in terms of volume of appointments, but undertreated in terms of what's actually being done in those appointments.

The gap between what the evidence supports and what most patients with LET receive is substantial. I see this both in the research and in the patients who arrive at my door having had multiple cortisone injections, months of passive treatment, and no structured loading program to speak of.

This post is aimed at RMTs, physiotherapists, athletic therapists, and other rehab clinicians who are managing this condition and want a clearer evidence-based framework.

What We're Actually Dealing With

The term "lateral epicondylitis" persists in clinical and patient-facing language, but the pathology is well-understood to be degenerative/dysregulative rather than primarily inflammatory. Histological studies consistently show angiofibroblastic dysplasia — disorganised collagen, increased ground substance, neovascularisation, and the absence of classic inflammatory infiltrates that the "-itis" label implies.

This matters clinically because it changes the treatment logic. Anti-inflammatory interventions (NSAIDs, corticosteroids) may have a short-term symptom role in early reactive stages, but they're not addressing the underlying pathology in chronic presentations. The driver of long-term recovery is tendon remodelling through mechanotherapy — and that requires load.

The primary structure involved is the common extensor origin, predominantly the extensor carpi radialis brevis (ECRB). Cozen's test (resisted wrist extension with elbow extended) and Mill's test remain clinically useful for provocative confirmation, though pain with resisted middle finger extension (Maudsley's test) can help implicate ECRB specifically.

Staging the Presentation

Cook and Purdam's continuum model remains useful for staging LET and matching your intervention:

Reactive tendinopathy: Short history (days to weeks), often following a load spike. Tendon is uniformly thick on imaging. Pain is high relative to structural change. Management priority is load reduction and isometric symptom control.

Tendon dysrepair: Weeks to months of symptoms. Early degenerative change on US or MRI, mixed echo texture. Still capable of positive adaptation with the right loading stimulus. This is where most presentations land.

Degenerative tendinopathy: Long history, significant structural disruption on imaging. Capacity for full reversal is limited, but symptom reduction and functional improvement are still achievable. Management expectations need calibration here.

In practice, most clinical LET presentations are in the dysrepair to early degenerative zone. The reactive end is often self-resolving; the patients you see have usually had it long enough for adaptation to be required.

Loading Protocols: What the Evidence Supports

There is no single definitive RCT protocol for LET loading, but the evidence base is consistent enough to outline a reliable framework.

Phase 1: Isometric Loading

Isometric wrist extension holds (4–5 reps × 40–60 seconds at approximately 70% MVC) have reasonable evidence for pain reduction in reactive and early dysrepair presentations. The mechanism isn't fully established — cortical inhibition, mechanosensory modulation, and direct tendon stimulus have all been proposed — but the clinical application is low-risk and useful for establishing symptom control early.

Position the patient with elbow near-extended, wrist in neutral to slight extension, forearm pronated. Use a dynamometer or standardised resistance for reproducibility if available.

Phase 2: Heavy Slow Resistance (HSR)

This is the workhorse of tendon rehab. Heavy slow resistance — eccentric-concentric loading at a controlled tempo, with progressive load increase over weeks — has consistently outperformed eccentric-only protocols in lower limb tendinopathy and is mechanistically well-supported for LET.

Primary exercise: seated wrist extension over the edge of a table, 3–4 sets × 8–15 reps, tempo of approximately 3 seconds eccentric / 3 seconds concentric. Start with a weight the patient can complete with form and no more than 3/10 pain. Progress load approximately every 1–2 weeks using a double progression model (reps first, then weight).

Secondary exercises: radial deviation (Tyler et al. twist bar exercises, or dumbbell equivalent), pronation/supination, and grip loading. These address the broader extensor chain and functional demands of grip-dependent work.

Frequency: 3 sessions per week is well-tolerated and allows adequate recovery between sessions. The 24-hour response rule applies — if symptoms haven't returned to baseline by the following morning, the previous session was too aggressive.

Phase 3: Functional and Work/Sport-Specific Loading

As the patient progresses through HSR, introduce loading patterns that mirror their occupational or recreational demands. For a tradesperson, this means adding forearm loads in tool-grip positions and work-relevant postures. For a mouse-heavy computer user, it means endurance tolerance in a sustained low-load position. For a racket sport athlete, it means dynamic forearm loading with velocity.

This phase is often skipped — either because the clinician discharges when pain is reduced or because the patient self-discharges. It's worth emphasising that this phase determines whether the patient gets a durable result or experiences recurrence on return to full activity.

The Cortisone Evidence: What to Say to Patients

Coombes, Bisset, and Vicenzino's 2013 RCT (JAMA) remains the most important reference for discussing cortisone with patients. At 4 weeks, corticosteroid injection significantly outperformed both physiotherapy and wait-and-see. By 52 weeks, it was the worst-performing group.

More recent systematic reviews confirm this pattern: short-term analgesia with corticosteroid is reliable, but it does not change the underlying tendon pathology and is associated with higher recurrence rates. There's also emerging evidence of tendon structural changes following repeated injections.

For patients who have had one injection and are still symptomatic, the message is that loading is the path forward — not a second injection. I've found this framing helpful: the injection reduced your pain enough to do the work; now we need to actually do the work.

Poor Prognostic Factors to Screen For

The following are associated with slower recovery and higher risk of chronic presentation:

Duration greater than three months. Dominant arm involvement. High pain severity at baseline (NRS 7+). Manual occupation or high-demand grip work. History of multiple corticosteroid injections. Elevated pain catastrophising (PCS-4 or similar brief screen). Sleep disruption (which impairs collagen synthesis and pain modulation). Comorbid metabolic conditions (diabetes, dyslipidaemia, obesity — all associated with worse tendon outcomes).

Screening for these early allows you to set appropriate expectations and, where relevant, advocate for multidisciplinary support. Patients with high catastrophising scores or significant psychosocial contributors will often plateau unless those factors are addressed in parallel.

A Note on Cervical Contribution

This is underscreened in LET. Neural involvement — whether from cervical radiculopathy (C6/C7), radial nerve sensitisation, or lateral antebrachial cutaneous nerve irritation — can coexist with or mimic LET. Neurodynamic testing (neural tension with elbow extension and wrist flexion in a ULNT2b position) and cervical clearing should be part of your initial assessment, particularly in patients who aren't responding to what should be an appropriate loading programme.

I've seen patients go through three months of wrist extension exercises for what turned out to have a significant cervical component driving their symptoms. A missed neural contributor can stall outcomes indefinitely.

Outcome Measures Worth Using

The Patient-Rated Tennis Elbow Evaluation (PRTEE) is the gold standard outcome measure for LET — 15 items covering pain and function, validated for this population. It's free, takes three minutes, and gives you a baseline and progress marker that's more sensitive than pain VAS alone.

Grip strength testing (handheld dynamometer, affected vs unaffected side) is also useful for tracking functional recovery over time. Asymmetry of greater than 20–25% correlates with functional limitation and helps motivate continued loading when symptoms have settled but strength hasn't caught up.

Final Thoughts

LET is a well-understood condition with a well-supported treatment approach. The challenge isn't the protocol — it's the execution: progressive loading over weeks and months, clear patient education, and the discipline not to revert to passive approaches when early progress is slow.

If you're treating this condition and finding that your patients plateau or recur, the questions worth asking are: are they actually loading progressively, or doing the same exercises with the same resistance for months? Are load spikes at work being monitored? Is there an unaddressed neural contributor?

The evidence is there. It just needs to be applied consistently.